Genflow Biosciences plc (LON:GENF)
London · Delayed Price · Currency is GBP · Price in GBX 1.900
+0.050 (2.63%)
Feb 12, 2026, 4:59 PM GMT
Genflow Biosciences Market Cap
Genflow Biosciences has a market cap or net worth of 9.38 million as of February 12, 2026. Its market cap has increased by 25.30% in one year.
Market Cap
9.38M
Enterprise Value
9.10M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.90
Market Cap Chart
Since January 17, 2022, Genflow Biosciences's market cap has decreased from 33.64M to 9.38M, a decrease of -72.12%. That is a compound annual growth rate of -26.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 9.38M | 2.70% |
| Dec 31, 2025 | 9.13M | 51.36% |
| Dec 31, 2024 | 6.03M | 44.72% |
| Dec 29, 2023 | 4.17M | -40.63% |
| Dec 30, 2022 | 7.02M | -79.13% |
| Jan 17, 2022 | 33.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptamer Group | 24.95M |
| Sareum Holdings | 23.47M |
| Fusion Antibodies | 20.00M |
| Oxford BioDynamics | 12.23M |
| IXICO | 9.50M |
| OptiBiotix Health | 7.90M |
| Futura Medical | 7.41M |
| CRISM Therapeutics | 7.24M |